MENLO PARK, Calif., Dec. 18, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 100,000 shares of... Read more
MENLO PARK, Calif., Dec. 18, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 100,000 shares of... Read more
Winter four-plex panel detects clinically most important respiratory viruses SARS-CoV-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV) Validation with nasopharyngeal swabs and oropharyngeal swabs for highest sensitivity Saliva sampling option convenient for patients, while also achieving high PCR sensitivity; saliva samples do not require extraction and enable a faster, resource-effective workflow NEHREN, Germany–(BUSINESS... Read more
The ‘Edison™ Accelerator’ Programme will give six healthcare start-ups access to world-class technical mentorship and business development support London, UK – December 17, 2020 – GE Healthcare and Wayra UK announce today the launch of GE’s regional programme to support digital health start-ups to http://www.ge.com/news/press-releases/ge-healthcare-wayra-uk-to-support-startups-to-develop-ai-applications-for-healthcare Read more
Ultrafast Multiplex LCMS System Shimadzu Scientific Instruments introduces the Nexera QX Multiplex LC-MS/MS System that uses multiple, alternating sample introduction streams for continuous operation of the mass spectrometer to significantly increase laboratory throughput and profitability. Nexera QX Multiple Stream technology eliminates waiting for column equilibration and system flushing. Nexera SIL-40 UHPLC autosamplers, stream-dedicated injection valves and... Read more
Luminex® Corporation (NASDAQ: LMNX) develops, manufactures, and markets proprietary biological testing technologies, with applications throughout the life-sciences industry. Luminex Corporation to Present at 39th Annual J.P. Morgan Healthcare Conference AUSTIN, Texas, Dec. 16, 2020 /PRNewswire/ — Luminex Corporation (Nasdaq: LMNX) today announced that Nachum “Homi” Shamir, Chairman, CEO and President, and Harriss Currie, Senior Vice President and... Read more
Automatable and reliable COVID-19 test rounds out Company’s menu of offerings for acute diagnostics of the virus WALTHAM, Mass. – December 16, 2020 – EUROIMMUN, a PerkinElmer, Inc. Company, today announced the launch of the CE marked SARS-CoV-2 Antigen ELISA for specific determination of the SARS-CoV-2 protein. The assay adds to the Company’s broad product... Read more
CHICAGO, December 16, 2020 – GE Healthcare today announced a multi-year agreement with Oregon Health & Science University (OHSU), Oregon’s only academic health center, that will allow OHSU to oversee and help provide care to ICU patients across eight hospital sites via a “Virtual ICU” (VICU), using the GE Healthcare Mural Virtual Care Solution. The... Read more
MENLO PARK, Calif., Dec. 16, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced initial findings from the company’s research collaboration with Labcorp that is focused on SARS-CoV-2 and the related immune response to COVID-19. Announced in April 2020, PacBio and... Read more